EPISODE · Nov 24, 2025 · 7 MIN
Hope in a Dose: CGT Podcast | Ep. 1 | What Makes CGT Trials Different?
from The Fortrea Podcast · host Marina
Host: Louise Kearney, Head of Cell and Gene Therapy, Strategy and Delivery at FortreaParticipant: Darby Thomas, Senior Scientific Director for Cell and Gene Therapies, Fortrea Description: In this first episode, we're discussing why we should think differently about cell and gene therapy, clinical trials, and the kinds of challenges to conventional trial design, and which means that we have to think about different operation models.
What this episode covers
Host: Louise Kearney, Head of Cell and Gene Therapy, Strategy and Delivery at Fortrea Participant: Darby Thomas, Senior Scientific Director for Cell and Gene Therapies, Fortrea Description: In this first episode, we're discussing why we should think differently about cell and gene therapy, clinical trials, and the kinds of challenges to conventional trial design, and which means that we have to think about different operation models.
NOW PLAYING
Hope in a Dose: CGT Podcast | Ep. 1 | What Makes CGT Trials Different?
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m